Added to YB: 2024-08-14
Pitch date: 2024-08-09
AZN [bullish]
AstraZeneca PLC
+16.07%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
Market Cap
GBP 288.6B
Pitch Price
GBP 79.93
Price Target
N/A
Dividend
1.72%
EV/EBITDA
15.45
P/E
28.03
EV/Sales
5.21
Sector
Pharmaceuticals
Category
growth
Show full summary:
ClearBridge Global Value Improvers Strategy Portfolio Holding: AstraZeneca PLC
AZN: Rallied on strong oncology pipeline results at ASCO, reinforcing leadership in breast & lung cancer treatments. Ambitious long-term growth targets announced. Positive outlook for company's future in largest oncology markets.
Read full article (1 min)